ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

Is A Rise Imminent For Bristol Myers Squibb Stock?
The stock price of Bristol Myers Squibb (NYSE:BMY) has seen a decline of 8% over the last month, while it is down 6% over the last week. This can partly be attributed to a larger decline in the broader markets with the S&P 500 also falling over 3% last wee
Announcement as on 05 December 2021

Compugen's stock jumps after Bristol Myers Squibb completes million investment into the company
Shares of Compugen Ltd. gained 13.4% in premarket trading on Thursday after Bristol Myers Squibb Co. completed a million investment in the company. Compugen's stock is down 48.1% so far this year, while the broader S&P 500 is up 25.2%. Market Pulse
Announcement as on 11 November 2021

Bristol Myers Squibb says sales of Revlimid, Eliquis increased in the third quarter
Shares of Bristol Myers Squibb Co. gained 0.6% in premarket trading on Wednesday after the drug maker beat expectations for the quarter and saw sales rise for two of its top-selling products. The company had earnings of .5 billion, or 69 cents per share
Announcement as on 27 October 2021

Bristol Myers: FDA Accepts SBLA For Opdivo Plus Yervoy, Opdivo Plus Chemotherapy In ESCC Patients
(RTTNews) - Bristol Myers Squibb (BMY) announced Monday that the U.S. Food and Drug Administration has accepted the supplemental Biologics License Applications or sBLA for both Opdivo (nivolumab) in combination with Yervoy (ipilimumab) and Opdivo in combin
Announcement as on 27 September 2021

Bristol Myers Reports FDA Priority Review For Relatlimab And Nivolumab Combination
(RTTNews) - Bristol Myers Squibb (BMY) said FDA has accepted for priority review the Biologics License Application for relatlimab and nivolumab fixed-dose combination in the treatment of adult and pediatric patients with unresectable or metastatic melanoma
Announcement as on 20 September 2021

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 59.3
  • 12Day Average: 58.9
  • 20Day Average: 59.18
  • 50Day Average: 59.75
  • 100Day Average: 57.11
  • 150Day Average: 53.22
  • 200Day Average: 51.68

BMY Indicators & signals

Indicator MACD (12,26,9)

59.03, 59.1, -0.12
Indicator MACD is in negative zone

Indicator ADX (14)

0, 21.17, 21.17
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
23 Thu Apr 2026 59.02 58.64 to 59.25 0.37% 0.92 times
22 Wed Apr 2026 58.80 58.68 to 59.70 -0.99% 1.06 times
21 Tue Apr 2026 59.39 57.79 to 59.73 0.44% 1.27 times
20 Mon Apr 2026 59.13 58.91 to 60.20 -1.73% 0.6 times
17 Fri Apr 2026 60.17 58.54 to 60.48 2.05% 1.63 times
16 Thu Apr 2026 58.96 57.66 to 58.98 1.85% 0.58 times
15 Wed Apr 2026 57.89 57.22 to 58.16 -0.36% 1.23 times
14 Tue Apr 2026 58.10 57.56 to 58.62 0.07% 0.52 times
13 Mon Apr 2026 58.06 57.55 to 58.90 -0.96% 1.49 times
10 Fri Apr 2026 58.62 58.46 to 59.80 -1.43% 0.7 times
09 Thu Apr 2026 59.47 58.54 to 59.69 0.46% 0.93 times
08 Wed Apr 2026 59.20 57.67 to 59.23 2.65% 1.63 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

 

Back to top